Targeting beta-catenin C-terminal domain/S1PR1 axis for vascular remodeling April 19, 2022 No Comments
Elastrin Therapeutics closes funding round to advance development of lead candidate April 8, 2022 No Comments
NPO-2270 ameliorates cardiac dysfunction more effectively than enalapril in models of HF April 7, 2022 No Comments
RSS